Moreover, miR-26a alleviated the inhibitory effect of AP-2α and the miR-26a inhibitor on glioma cells by upregulating the expression of Nanog/Sox2 and the IL6/Jak2/STAT3 signaling pathway (Figure 8D). The gene discussed is JAK2; the disease is central nervous system cancer.